KYLE STEPHENS: Open Payments
NPI 1205204518 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$745 in 38 payments from 10 companies in 2025. Trend: 2023 $390 · 2024 $608 · 2025 $745
Food & beverage: $745
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 17 | $188 |
| Edwards Lifesciences Corporation | 2 | $153 |
| Novo Nordisk Inc | 4 | $90 |
| AstraZeneca Pharmaceuticals LP | 5 | $90 |
| Lilly USA, LLC | 3 | $76 |
| ABBVIE INC. | 2 | $47 |
| Almatica Pharma LLC | 2 | $40 |
| Eisai Inc. | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: SAPIEN 3 Ultra RESILIA, OTEZLA, MOUNJARO, EVENITY, AIRSUPRA, Wegovy, Ozempic, LOREEV XR.
Industry payments across CA — which companies pay providers there.
